SD 1008

Modify Date: 2024-01-09 12:29:15

SD 1008 Structure
SD 1008 structure
Common Name SD 1008
CAS Number 960201-81-4 Molecular Weight 329.35
Density N/A Boiling Point N/A
Molecular Formula C18H19NO5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SD 1008


SD-1008 is a potent JAK inhibitor. SD-1008 inhibits tyrosyl phosphorylation of STAT3, JAK2 and Src. SD-1008 also reduces STAT3-dependent luciferase activity. SD-1008 enhances apoptosis induced by Paclitaxel in ovarian cancer cells via directly blocking the JAK-STAT3 signaling pathway[1].

 Names

Name Dimethyl (1R,5R,6R,7S)-8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-en e-6,7-dicarboxylate-dimethyl (1S,5S,6S,7R)-8-benzyl-4-oxo-8-aza bicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate (1:1)

 SD 1008 Biological Activity

Description SD-1008 is a potent JAK inhibitor. SD-1008 inhibits tyrosyl phosphorylation of STAT3, JAK2 and Src. SD-1008 also reduces STAT3-dependent luciferase activity. SD-1008 enhances apoptosis induced by Paclitaxel in ovarian cancer cells via directly blocking the JAK-STAT3 signaling pathway[1].
Related Catalog
Target

JAK2

STAT3

References

[1]. Duan Z, et al. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells. Mol Pharmacol. 2007;72(5):1137-1145.

 Chemical & Physical Properties

Molecular Formula C18H19NO5
Molecular Weight 329.35
Exact Mass 658.25300
PSA 145.82000
LogP 1.78920
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.